Prognostic value of atypical B cells in breast cancer

Esmeralda García-Torralba1, Lorenzo Galluzzi2, Aitziber Buqué2

  • 1Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA; Department of Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, Spain; Department of Medicine, Medical School, University of Murcia, Murcia, Spain; IMIB-Arrixaca, Murcia, Spain.

Trends in Cancer
|October 1, 2024
PubMed